This journal is a fully open access journal. All articles are made freely and permanently available online immediately upon publication without subscription fees or access restrictions, ensuring unrestricted access to scholarly research for readers worldwide.
Users are free to read, download, copy, distribute, print, search, link to, and use the full text of published articles for any lawful purpose without requesting prior permission from the publisher, provided that the terms of the applicable Creative Commons license are observed. This policy supports the broad dissemination and exchange of scholarly knowledge.
All articles published in this journal are licensed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license.
Under this license, anyone may copy, distribute, reproduce, adapt, remix, transform, and build upon the published material in any medium or format, including for commercial purposes, provided that:
The copyright in all published articles is held by the Institute, owner of this journal. Authors grant the copyright holder and the publisher the necessary rights to publish, disseminate, archive, and preserve the published work. The Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license governs the reuse of all published content unless otherwise stated.
All articles are assigned Digital Object Identifiers (DOIs) through Crossref to ensure persistent and reliable access. The journal supports long-term digital preservation and accessibility through appropriate archiving and indexing services.
All manuscripts submitted to this journal must be original works that have not been previously published and are not under consideration for publication elsewhere. Authors are responsible for ensuring that their submissions do not infringe upon the copyright or other intellectual property rights of any third party.
Upon acceptance of a manuscript for publication, the author(s) agree to transfer the copyright of the published work to Era’s Journal of Medical Research, the journal's owner, in accordance with the journal's Copyright Transfer Agreement. The copyright holder retains the exclusive right to publish, reproduce, distribute, archive, preserve, and communicate the published work in all media and formats.
The journal publishes all articles under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license.
This license permits anyone to copy, redistribute, reproduce, adapt, remix, transform, and build upon the published material for any purpose, including commercial use, provided that:
Although copyright is held by Era’s Journal of Medical Research, authors retain the right to be identified as the creators of their work and may use the published version for personal, academic, educational, and non-commercial professional purposes, including teaching, conference presentations, inclusion in a thesis or dissertation, and posting bibliographic information on personal or institutional webpages, provided that proper acknowledgement of the original publication in this journal is given.
Authors are responsible for obtaining written permission to reproduce any copyrighted material, including figures, tables, photographs, illustrations, or substantial excerpts, where such permission is required. Copies of the relevant permissions must be provided to the journal before publication.
Any reuse of published content must comply with the terms of the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license unless otherwise specified by the journal.
Attribution-ShareAlike 4.0 International (CC BY-SA 4.0)
Authors retain the following rights:
Users are permitted to read, download, copy, distribute, print, search, and link to the full texts of articles, and to use them for any lawful commercial purpose, provided proper attribution is given and any derivative works follow the same license.
The publisher retains the right to:
All submitted manuscripts are subjected to a double-blinded peer review process. Also, it goes through necessary plagiarism check. After ensuring the completeness of the article, it is forwarded to undisclosed reviewers for peer review and detailed responses. Authors mostly get the decision on their manuscript within 4–6 weeks (revision stages may extend this timeline by up to 2 additional weeks).
Original research in humans and animals require a letter of approval from the Institutional Ethics Committee or a letter stating that the Institutional Review Board has waived the need for informed consent. For prospective interventional trials, registration with trial registries such as Clinicaltrials.gov is mandatory.
All research shall be conducted as per the WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Participants (updated in 75th WMA General Assembly, Helsinki, Finland, October 2024 https://www.wma.net/policies-post/wma-declaration-of-helsinki/ ).
This journal does not charge any fees for manuscript submission, processing, or publication. Authors are not required to pay any article processing charges (APC) or submission fees at any stage of the publication process.
All articles are published free of cost as part of the journal’s commitment to open access and the dissemination of scientific knowledge.
Era’s Journal of Medical Research is a Tri-annually periodical publishing 3 issues in a year.
Era’s Journal of Medical Research provides for long-term digital preservation through Portico.
The Journal permits authors to self-archive the published version of the record immediately without embargo on their own webpages, on institutional webpages, and in other repositories with full link to the article webpage.
This Publication Ethics and Malpractice Statement is based on the Code of Conduct and Best Practice Guidelines for Journal Editors as per Committee on Publication Ethics , 2011, ICMJE & WAME .
While advertisements may be crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content.
Editorial independence will be maintained and advertisements shall be treated separately.
Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
Journal will not accept advertising for products or services known to be harmful to health, such as tobacco and alcohol products.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Articles will be checked for plagiarism. Manuscripts are evaluated for plagiarism using similarity tools, and editorial judgment determines acceptability. Authors are encouraged to ensure originality prior to submission using appropriate similarity plagiarism checking tools to ensure higher possibility of acceptance.
The authors must ensure their plagiarism-free manuscript. In case of any plagiarism allegation in any form in a published article, the process of investigation will follow under ICMJE and COPE Guidelines. If proven, the article shall be retracted and further necessary actions may be taken.
We check for plagiarism in all articles to ensure article quality through iThenticate.
The publication of the article shall always be subject to the right of the journal to retract and remove the article from its website/portal if it is found at any time that:
The publication of the article shall always be subject to the right of the journal to retract and remove the article from its website/portal if it is found at any time that:
The best way to reach us is by email. Complaints should ideally be made to the person the complainant is already in contact with over the matter being complained about. If that is not appropriate, please email complaints@ejmr.org.
Whenever possible, complaints will be dealt with by the relevant member of the editorial staff. If that person cannot deal with the complaint, he or she will refer it to a section editor or the executive editor.
Our journal recognizes that generative AI and AI-assisted tools may be used in scholarly research and manuscript preparation. To maintain research integrity, transparency, accountability, and confidentiality, authors, reviewers, and editors are expected to comply with the following principles.
Generative AI tools, including chatbots and other AI systems, cannot be credited as authors or co-authors of a manuscript. Authorship and accountability remain the responsibility of human authors who meet the applicable authorship criteria.
Authors must transparently disclose the use of generative AI or AI-assisted tools when such tools have contributed to the preparation, analysis, generation, or substantial modification of manuscript content.
Routine use of basic spelling, grammar, or language-editing tools that does not generate substantive content generally does not require disclosure. However, authors remain responsible for the final manuscript.
Where generative AI has been used to generate new text, tables, illustrations, computer code, analytical outputs, or other substantive material, authors should clearly disclose this use in the manuscript.
Authors should provide sufficient information about the AI tool and its use to allow appropriate editorial and scientific evaluation. Where relevant, this should include the name/version of the AI tool, the nature and purpose of its use, and the prompts or other information necessary to understand or reproduce the AI-assisted work.
Authors remain fully responsible for the accuracy, originality, integrity, and ethical acceptability of their manuscript, including any content produced or modified with the assistance of generative AI.
AI-generated material must be carefully verified. Authors are responsible for identifying and correcting inaccurate, fabricated, incomplete, biased, or misleading information and for ensuring that all references and citations are genuine, appropriate, and accurately represented.
The use of AI does not exempt authors from requirements concerning plagiarism, fabrication, falsification, copyright, proper attribution, conflicts of interest, or research ethics.
Authors, reviewers, and editors must not upload confidential manuscripts, unpublished data, personal information, or other protected material to generative AI systems when doing so could compromise confidentiality, intellectual property, privacy, or the integrity of the peer-review process.
Editors and peer reviewers should disclose to the relevant editorial parties any use of generative AI in manuscript evaluation, review preparation, correspondence, or editorial decision-making.
Reviewers and editors remain responsible for the content and citations generated with AI assistance. They must also protect the confidentiality of submitted manuscripts and should not use AI tools in a manner that exposes confidential manuscript material.
The journal may use appropriate technological and editorial measures to identify potentially undisclosed AI-generated or AI-assisted content. Detection tools may support editorial assessment but will not, by themselves, constitute definitive evidence of inappropriate AI use.
The journal reserves the right to request clarification or additional information from authors concerning the use of AI in a submitted manuscript.
Any undisclosed or inappropriate use of generative AI that compromises the originality, accuracy, attribution, confidentiality, or integrity of scholarly work may be considered during editorial assessment and may be handled in accordance with the journal's publication ethics and misconduct procedures.
This policy is based on the recommendations of the World Association of Medical Editors (WAME) concerning chatbots and generative AI in scholarly publications and may be updated as AI technologies and international publishing standards evolve.
WAME – Chatbots, Generative AI, and Scholarly Manuscripts
Latest WAME recommendations:
WAME – Chatbots, Generative AI, and Scholarly Manuscripts
EJMR follows a transparent, fair, and rigorous editorial process for the selection and publication of scholarly articles. Manuscripts are evaluated on the basis of their originality, academic quality, relevance to the journal's scope, ethical standards, and contribution to the field.
All submitted manuscripts undergo an initial editorial assessment before being sent for peer review. The editorial team evaluates the manuscript for:
Manuscripts that are clearly outside the journal's scope, substantially incomplete, or do not meet the journal's basic editorial requirements may be rejected at this stage without external peer review.
Submitted manuscripts are screened for plagiarism and inappropriate textual similarity using appropriate plagiarism and similarity-checking tools.
The presence of similarity does not automatically constitute plagiarism, as legitimate quotations, references, standard terminology, and commonly used technical expressions may contribute to similarity. However, manuscripts containing substantial unattributed copying, plagiarism, duplicate publication, or other forms of inappropriate content reuse may be rejected.
Where necessary, authors may be asked to provide clarification or revise the manuscript before the editorial process continues.
Manuscripts that successfully pass the initial editorial screening are normally subjected to a double-blind peer-review process, in which the identities of the authors and reviewers are concealed from each other to the extent practicable.
Manuscripts are evaluated by qualified reviewers based on factors including:
Based on the reviewers' comments and the independent judgment of the editorial team, a manuscript may receive one of the following decisions:
A manuscript may be rejected when the reviewers or editors identify substantial concerns relating to originality, methodology, validity, ethical compliance, academic contribution, or other aspects that cannot be adequately addressed through revision.
The final publication decision rests with the Editor-in-Chief/Editorial Board and is not determined solely by the recommendation of any individual reviewer.
A manuscript may be rejected at any stage of the editorial process for reasons including, but not limited to:
The journal aims to ensure that editorial decisions are based on the academic and ethical merits of the manuscript. Decisions are not based on an author's nationality, institutional affiliation, gender, race, religion, personal characteristics, or other irrelevant considerations.
Editors and reviewers are expected to disclose relevant conflicts of interest and maintain the confidentiality of submitted manuscripts.
Invitation to revise a manuscript does not constitute a guarantee of acceptance. Revised manuscripts may be returned to the original reviewers or evaluated by the editorial team before a final decision is made.
The journal may reject a manuscript if the required revisions are not adequately addressed or if significant concerns remain.
The journal is committed to maintaining a rigorous and ethical peer-review process. The editorial team reserves the right to take appropriate action if concerns regarding plagiarism, research misconduct, unethical practices, or undisclosed conflicts of interest arise before or after publication.
Our article selection process is designed to ensure that published articles meet appropriate standards of originality, academic quality, research integrity, and relevance to the journal's readership.
Once an academic or scientific paper has been published by a journal, it's sometimes too late to withdraw it. Why because it is so important to learn all about the journal and be certain that it is the right home for your research before submitting the manuscript. Era’s Journal of Medical Research are committed to upholding publication ethics and providing high-quality articles to advance the intellectual agenda. We anticipate authors to follow the publication ethics as well as the quality of their articles. Some authors request withdrawal of manuscript forms the publication process after submission. In some cases, the withdrawal request is made very late, when the article is only a few days away from publication in the journal. Withdrawing manuscripts after publication may cause amount of time to be wasted in processing the manuscripts by the editors, reviewers, and the editorial board members. Authors are requested to decide before submitting the manuscript. Ideally, these should be decided even before beginning to write the manuscript.
We request the authors, especially to the corresponding author or the first author, to address the following issues before submitting the manuscript:
Article may be withdrawn within 2 days of submission of the article. The withdrawal request must be followed via mail at ejmrediotor1@gmail.com/Contact us page. Manuscripts (articles) once processed for peer review process or published online shall be withdrawn with penalty paid to the Editorial office of Era’s Journal of Medical Research. Withdrawal of manuscript after publication if paid by the authors, the publication charges will not be refunded. In limited number of cases, it may be necessary to remove a published article from our online platform. This will only happen if an article is clearly defamatory, or contravene, legal rights, or we have good reason to expect that it will be, the subject of a court order, or where the article, if acted upon, may pose a serious health risk. In such circumstances, the Editorial office of Era’s Journal of Medical Research, will provide the corresponding author a formal letter of manuscript withdrawal.
If you would like to withdraw your paper from a journal, you will have to send a withdrawal request. You should mention the title of the article, the manuscript ID, the submission date, and the reason for withdrawal. Additionally, you should request withdrawal from the editor, as the withdrawal process will be completed only after you receive confirmation.
Dear Mr. XXX [Editor's Name],
I would wish to withdraw my manuscript titled XXXX [Title of paper] from further consideration by your journal. The manuscript ID is XXXX and the submission date was XXXX. The reason for withdrawal is XXXX.
Please confirm that the withdrawal process is complete. I apologize for any inconvenience caused.
Sincerely,
XXXX [Your name and contact details]